Drug · DIN 02475472
RADICAVA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 1, 2025; first marketed October 29, 2019.
- Drug Identification Number (DIN)
- 02475472
- Company (DIN owner)
- Mitsubishi Tanabe Pharma CorporationChuo-Ku, Osaka-Fu, Japan
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Edaravone N07XX14
- Class
- Human
- Record last updated
- June 10, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EDARAVONE | 30 MG | 100 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 3, 2018: NOC 21386New Drug Submission (NDS)
Other DINs named RADICAVA
- DIN 02532611 · Marketed